STOCK TITAN
  1. Home
  2. Sec-filings
  3. OPCH
  4. [Form 4] Option Care Health, Inc. Insider Trading Activity

Option Care director gets $200K stock awards

Option Care Health director Timothy P. Sullivan reported two stock awards from the company.

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Option Care Health director Timothy P. Sullivan reported two stock awards from the company. On May 20, 2026 he acquired 4,836 shares of common stock at a reference price of $22.23 per share as a restricted stock unit award reflecting $200,000 of value. He also received 8,997 restricted stock units in lieu of cash retainer fees, with both grants based on the same closing share price. All these restricted stock units vest in full on May 20, 2027, representing routine equity-based director compensation rather than open-market share purchases.

Positive

  • None.

Negative

  • None.
Insider SULLIVAN TIMOTHY P
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 8,997 $0.00 $0.00
Grant/Award Common Stock 4,836 $22.23 $108K
Holdings After Transaction: Common Stock — 87,216 shares (Direct)
Footnotes (2)
  1. F1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
  2. F2. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
Equity award shares 4,836 shares Restricted stock unit award reflecting $200,000 of value on May 20, 2026
Reference share price $22.23 per share Closing price used to calculate one RSU grant on May 20, 2026
Fee replacement RSUs 8,997 shares Restricted stock units received in lieu of cash retainer payments
Total RSUs granted 13,833 shares Combined director grants on May 20, 2026
Holdings after first grant 87,216 shares Common stock reported following the 4,836-share award
Holdings after second grant 82,380 shares Common stock reported following the 8,997-share award
Vesting date May 20, 2027 All reported restricted stock units vest in full on this date
restricted stock units financial
"The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
cash retainer payments financial
"The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027."
closing price financial
"based on the closing price of the issuer's common stock on May 20, 2026."
grant, award, or other acquisition financial
"transaction code description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Option Care Health (OPCH) report for Timothy P. Sullivan?
Option Care Health reported that director Timothy P. Sullivan received two grants of restricted stock units totaling 13,833 shares on May 20, 2026 as equity compensation and fee replacement, rather than buying shares in the open market.

How many Option Care Health (OPCH) shares were granted to Timothy P. Sullivan?
Timothy P. Sullivan was granted 4,836 shares tied to a $200,000 award and 8,997 shares in lieu of cash retainer fees, for a combined 13,833 restricted stock units, all referenced to the same closing share price.

At what price were Timothy P. Sullivan’s OPCH stock awards calculated?
The restricted stock units were calculated using the May 20, 2026 closing price of Option Care Health common stock, including one grant recorded at $22.23 per share to reflect $200,000 of value and a separate grant tied to director cash fees.

When do Timothy P. Sullivan’s Option Care Health (OPCH) restricted stock units vest?
All of Timothy P. Sullivan’s reported restricted stock units vest in full on May 20, 2027, meaning he must remain eligible through that date before the awards fully convert into common shares he can own outright.

Were Timothy P. Sullivan’s OPCH transactions open-market buys or compensation grants?
The filing shows compensation-related grants, not open-market purchases. Both transactions are coded as awards of restricted stock units, with one replacing cash retainer payments and the other reflecting a $200,000 equity value grant.

Does the Option Care Health (OPCH) Form 4 show any insider sales by Timothy P. Sullivan?
The Form 4 shows no sales by Timothy P. Sullivan. All reported activity involves acquisition of restricted stock units as director compensation, with no dispositions, exercises, or open-market selling reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SULLIVAN TIMOTHY P
(Last)(First)(Middle)
C/O OPTION CARE HEALTH, INC.
3000 LAKESIDE DRIVE, SUITE 300N
(Street)
BANNOCKBURN ILLINOIS 60015
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A8,997(1)A$082,380D
Common Stock05/20/2026A4,836(2)A$22.2387,216D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
2. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
/s/ Michael Bavaro, attorney-in-fact for Mr. Sullivan05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on OPCH

Trending in the feed

Open the live feed